{4-[3-(6,7-diethoxy-quinazolin-4-ylamino)-phenyl]-thiazol-2-yl}-methanol

{4-[3-(6,7-diethoxy-quianazolin–4–ylamino)-phenyl]-thiazol–2–yl}-methanol is a synthetic small molecule featuring a quinazoline core with diethoxy substitutions and a thiazole-methanol moiety. It is catalogued as an experimental compound in chemical and pharmacological databases but does not have an established clinical use or approved indication. The structure suggests it belongs to the class of aromatic heteropolycyclic compounds and may be related to kinase inhibitor scaffolds commonly found in anticancer research; however, there is no direct evidence of its mechanism of action or biological target from available data[1][2][9]. No clinical trials or regulatory approvals are reported for this compound[7].

Other names

(4-{3-[(6,7-diethoxyquinazolin-4-yl)amino]phenyl}-1,3-thiazol-2-yl)methanol(4-(3-(6,7-DiethoxyQuinazolin4Ylamino)PhenylThiazol2Yl)Methanol)